Asia Pacific Mobile Health Market Size, Share, Industry, Forecast and outlook (2024-2031)

Asia Pacific Mobile Health Market Overview

The Asia Pacific Mobile health market is estimated to reach a CAGR of 37.82% during the forecast period 2024-2031. Due to advancements in health care and research, Asia Pacific is expected to see the most significant market growth throughout the projected period.

mHealth is an emerging sector within the healthcare industry, contributing to the enhancement of life quality through its services. With increasing digitalization over the past few years, the adoption of mHealth technologies such as wearable devices, smartphones and tablets has substantially increased, thereby increasing mHealth market growth. 

Active government initiatives, a preference for cost-effective care, and an increase in chronic diseases among the geriatric population primarily drive the development of the market.  The growing trend of adult fitness and wellness has led to increased utilization of health services. 

As a result, industry participants operating in the market to provide remote monitoring with preventative and diagnostic solutions, amongst other benefits, are anticipated to significantly drive growth.

Market Scope

For more details on this report Request for Sample

Market Drivers

The rising incidence of chronic diseases has led to a substantial surge in the demand for mobile health (mHealth).

The growing prevalence of chronic illnesses has significantly increased the demand for mHealth services. According to the World Health Organization (WHO), cardiovascular diseases account for 41% of total deaths in China. Additionally, more than 65 million people in India suffer from diabetes. Therefore, there is an increased need for mHealth services such as remote patient monitoring, online delivery of medications, online consultations and diagnostic solutions. 

The Chronic neurological illnesses in regions with geriatric population, including Dementia are expected to increase substantially, thereby increasing the usage of neurological monitoring applications and devices. Hence, the growing prevalence of chronic illnesses is expected to propel the growth of the Asia Pacific mHealth market in the forthcoming years.

Market Restraints

The lack of awareness among the senior population of APAC regarding the benefits of mHealth is one of the most significant factors inhibiting the growth of the mHealth market in Asia-Pacific. In addition, the extended time required for regulatory bodies to approve applications, the lack of data privacy, and inaccurate data from monitoring devices hinder the market growth in this region.

Market Segmentation

Asia Pacific Mobile Health Market is segmented based on Service, Application, and End-User.

By Service 

• Fitness Services
• Diagnosis & Consultation Services
• Remote Monitoring
• Treatment Services
• Prevention Services

By Application 

• Body and Temperature Monitors
• Blood Glucose Monitors
• Cardiac Monitors
• Hemodynamic Monitors
• Neurological Monitors
• Others

By End User:

• Patients with chronic diseases
• Physicians
• Hospitals
• Parents/Relatives
• Others

By End User Analysis: The hospital segment accounts for the highest market Share.

Physicians segment accounted for a large portion of the market. The higher sector share may be ascribed to mHealth's offerings, which include enhanced online physician-patient engagement leading to better patient outcomes. The population living in rural places has also had easier access to mHealth services, which may be attributed to doctors' embrace of mHealth technology. 

The point-of-care tools with improved decision-making are now available to doctors with mHealth technology. Therefore, in an effort to offer better healthcare facilities, doctors are increasingly embracing mHealth apps. Therefore, the physician sector will contribute to the market's growth throughout the Asia Pacific area.

By Country:

• India
• China
• Japan
• Rest of APAC

Market Regional Insights:

By region, the Asia Pacific Mobile Health market is segmented into India, China, Japan and the Rest of APAC.

Geographically, the APAC mHealth market accounted for a significant proportion of the global market in 2022 and is expected to expand at the quickest CAGR during the forecast period as a result of the rising usage of digital technologies in the healthcare sector. Due to the presence of multiple market competitors and the increased adoption of mobile health apps, China is expected to account for the largest share of the APAC market in 2022, and this trend is expected to continue over the forecast period. The availability of technology advancements such as 5G in China benefits the Chinese mHealth industry. During the covid-19 epidemic, greater use of telemedicine services was seen in China in order to minimize viral transmission among the Chinese populace.

During the projected period, the Japan mHealth industry is expected to account for a sizable portion of the APAC market. The expanding patient population suffering from chronic illnesses such as cancer, heart disease, and diabetes is driving the Japanese market's rise. People are increasing their healthcare spending to improve their quality of life by adopting home healthcare gadgets. Chronic illnesses are responsible for an estimated 60% of fatalities in Japan. 

In Japan, mHealth apps include an instructional film that helps users improve their health literacy and lower the risk of sickness in their everyday lives. The government has issued many standards for creating movies aimed at raising public awareness about certain illnesses.

Asia Pacific Mobile Health market Players

Samsung Electronics Co., Ltd., Huawei Technologies Co., Ltd., Omron Healthcare are some of the notable players in the APAC mHealth market.